Skip to main content
. 2018 Apr 19;13(4):e0196163. doi: 10.1371/journal.pone.0196163

Table 4. Comparison of the percentage and concentration of each IgG4 N-glycan between patients with IgG4-related disease with or without autoimmune pancreatitis.

Autoimmune pancreatitis (+)
n = 4
Median (range)
Autoimmune pancreatitis (−)
n = 8
Median (range)
p value
G0 (%) 35.8 (35.09–44.7) 37.3 (30.7–48.2) NS
G0 (pmol/mg) 5458.4 (4039.6–7698.2) 7079.9 (5641.9–9210.5) NS
G1 (%) 24.5 (22.5–27.0) 23.3 (21.6–27.2) NS
G1 (pmol/mg) 3786.5 (2724.5–4318.8) 4328.0 (3240.0–6065.8) NS
G2 (%) 38.1 (32.2–40.6) 38.5 (27.7–45.5) NS
G2 (pmol/mg) 5765.3 (4283.5–6157.5) 6750.1 (3505.8–12763.2) NS
G3 (%) 0.3 (0–0.5) 0.5 (0–1.1) NS
G3 (pmol/mg) 40.9 (0–91.1) 69.3 (0–251.2) NS
F0 (%) 5.1 (2.7–9.6) 3.6 (2.0–6.5) NS
F0 (pmol/mg) 674.7 (414.2–1537.1) 735.0 (394.8–942.5) NS
F1 (%) 94.9 (90.4–97.3) 96.4 (93.5–98.0) NS
F1 (pmol/mg) 14602.9 (10324.5–16583.9) 17751.7 (11901.2–27255.3) NS
S0 (%) 61.2 (58.5–64.8) 61.8 (52.8–69.7) NS
S0 (pmol/mg) 9148.3 (7009.4–11160.7) 10737.9 (8817.4–15631.6) NS
S1 (%) 22.9 (21.1–27.5) 23.3 (19.5–26.1) NS
S1 (pmol/mg) 3618.8 (2432.1–4393.2) 4157.1 (2470.9–7002.6) NS
S2 (%) 14.3 (14.0–17.3) 15.0 (10.7–21.2) NS
S2 (pmol/mg) 2328.8 (1605.7–2622.0) 2565.0 (1358.1–5405.3) NS